Gut Inflammation and Indoleamine Deoxygenase Inhibit IL-17 Production and Promote Cytotoxic Potential in NKp44+ Mucosal NK Cells During SIV Infection
Overview
Authors
Affiliations
Natural killer (NK) cells are classically viewed as effector cells that kill virus-infected and neoplastic cells, but recent studies have identified a rare mucosal NK- cell subpopulation secreting the TH17 cytokine IL-22. Here, we report identification of 2 distinct lineages of mucosal NK cells characterized as NKG2A(+)NFIL3(+)RORC(-) and NKp44(+)NFIL3(+)RORC(+). NKG2A(+) NK cells were systemically distributed, cytotoxic, and secreted IFN-γ, whereas NKp44(+) NK cells were mucosae-restricted, noncytotoxic, and produced IL-22 and IL-17. During SIV infection, NKp44(+) NK cells became apoptotic, were depleted, and had an altered functional profile characterized by decreased IL-17 secretion; increased IFN-γ secretion; and, surprisingly, increased potential for cytotoxicity. NKp44(+) NK cells showed no evidence of direct SIV infection; rather, depletion and altered function were associated with SIV-induced up-regulation of inflammatory mediators in the gut, including indoleamine 2,3-dioxygenase 1. Furthermore, treatment of NKp44(+) NK cells with indoleamine 2,3-dioxygenase 1 catabolites in vitro ablated IL-17 production in a dose-dependent manner, whereas other NK-cell functions were unaffected. Thus lentiviral infection both depletes and modifies the functional repertoire of mucosal NK cells involved in the maintenance of gut integrity, a finding that highlights the plasticity of this rare mucosal NK-cell population.
IL-22, a vital cytokine in autoimmune diseases.
Li J, Wu Z, Wu Y, Hu X, Yang J, Zhu D Clin Exp Immunol. 2024; 218(3):242-263.
PMID: 38651179 PMC: 11557150. DOI: 10.1093/cei/uxae035.
Innate adaptive immune cell dynamics in tonsillar tissues during chronic SIV infection.
Shukla R, Gunasena M, Reinhold-Larsson N, Duncan M, Hatharasinghe A, Cray S Front Immunol. 2023; 14:1201677.
PMID: 37671159 PMC: 10475724. DOI: 10.3389/fimmu.2023.1201677.
Sugawara S, Hueber B, Woolley G, Terry K, Kroll K, Manickam C PLoS Pathog. 2023; 19(9):e1011629.
PMID: 37669308 PMC: 10503717. DOI: 10.1371/journal.ppat.1011629.
Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models.
Boulay A, Trabanelli S, Boireau S, Boyer-Clavel M, Nisole S, Romero P Immunohorizons. 2023; 7(3):243-255.
PMID: 37000496 PMC: 10563434. DOI: 10.4049/immunohorizons.2300007.
The initial interplay between HIV and mucosal innate immunity.
Caputo V, Libera M, Sisti S, Giuliani B, Diotti R, Criscuolo E Front Immunol. 2023; 14:1104423.
PMID: 36798134 PMC: 9927018. DOI: 10.3389/fimmu.2023.1104423.